Results From A First-In-Human, Proof-Of-Concept Phase 1 Trial In Pretreated B-Cell Malignancies For Loxo-305, A Next-Generation, Highly Selective, Non-Covalent Btk InhibitorAnthony R. Mato,Ian W. Flinn,John M. Pagel,Jennifer R. Brown,Chan Y. Cheah,Catherine C. Coombs,Manish R. Patel,S. Michael Rothenberg,Donald E. Tsai,Nora C. Ku,Michael L. WangBLOOD(2019)引用 34|浏览0暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要